Most Americans have been exposed to several coronaviruses before Covid-19 The epidemic, which can cause a specific antibody to be stimulated in the event of a COVID-19 infection, a new scientific study shows.
Published in the academic journal Nature CommunicationsThe peer-reviewed study examined how the body’s immune system responds to COVID-19 after previous exposure to at least one of the other four coronaviruses common in the United States that cause the relatively benign disease popularly known. like a cold.-
The study found that Antibody In question, it interacts not only with SARS-CoV-2, which causes COVID-19, but also with SARS-CoV-1, which causes severe acute respiratory syndrome (SARS).-
This antibody is likely produced by a memory B cell previously exposed to the common cold, according to Rice Andrabie, the study’s lead author, who works as a researcher in the Department of Immunology and Microbiology at the Scripps Research Institute, according to the website. medical news.-
These cells are essential parts of the immune system and work by remembering diseases that have already entered the body.
The study results are important because they could not only help pave the way for better vaccines and treatments, but they could also help fight future strains of coronavirus that may emerge.
Professor Dennis Burton, one of the authors of the study, said, according to News Medical, “There will likely be another deadly coronavirus in the future – and if it does, we want to be better prepared.”
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). Presentatie (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}
“Our identification of an antibody reactive against SARS-CoV-2 and the most common coronaviruses is a promising development towards a broad spectrum vaccine or treatment.”
–
